Pfizer did have the power to block other therapeut
Post# of 145339
![](/assets/46931549/no_avatar_available_thumb.jpg)
The Drugs for Neglected Diseases initiative (DNDi) expressed concern on behalf of a consortium of 26 African and global research bodies that the drug company would not provide access to Paxlovid.1 It said that the refusal to cooperate set a “dangerous precedent” given the number of other antivirals in the pipeline and that it was difficult to understand the rationale for the decision in a global pandemic.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)